USPTO serial 98018339
LIFENET HEALTH GIVE HEALING EVERY ADVANTAGE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, CYNTHIA RINALDI
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LIFENET HEALTH GIVE HEALING EVERY ADVANTAGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Virginia Beach, VA
Virginia Beach, VA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William Jackson Matney
William Jackson Matney Matney Legal Group PLLC1818 Library St, Suite 500Reston, VA 20190United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cells for scientific, laboratory, and medical research use; Cell culture media for scientific, laboratory, and research use; biological tissue, namely, bone, blood, muscle, organ, skin and vascular tissue for scientific, laboratory, and medical research use; in vitro assays for scientific, laboratory, and medical research use; in vitro assays for drug research use; human cells, biological tissue being bone, blood, muscle, organ, skin and vascular tissue, and in vitro assays for scientific and medical research use for drug discovery and development applications, and toxicity research studies | ACTIVE | — |
| 005 | Human allograft tissue and cells; biological bone, skin, placental, amnion, chorion, umbilical cord, tendons, cartilage, veins, arteries, heart valves, and cardiovascular tissues intended for subsequent implantation; human allograft tissue for use in vascular surgery and vascular treatment; human allograft tissue for orthopedic use; human allograft tissue for use in burn and wound treatment; human allograft tissue for use in treatment of musculoskeletal disorders and conditions; Cells for medical or clinical use; Cell growth media for growing cells for medical or clinical use; medical diagnostic reagents; Dressings and bandages for skin wounds; Wound healing system comprised of medical dressing and bandages for skin wounds; Medical dressings; Gauze for dressings; Burn dressings; Surgical dressings; Medical dressings for negative pressure wound therapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations for dermatological conditions; Balms for pharmaceutical purposes; medical ointments for treating dermatological conditions, burns, pain and topical infections; Medicated lotions for body; Pharmaceutical preparations for skin care; Pharmaceutical preparations for pain relief; Antibiotics; anti-infectives; anti-fungal pharmaceutical preparations | ACTIVE | — |
| 009 | Bioreactors for laboratory use | ACTIVE | — |
| 042 | Testing, inspection or research of pharmaceuticals; medical research; scientific research; Providing medical testing services and information in the field of cancer research and disease classification; Toxicology services; pharmaceutical drug development services; pharmaceutical research services; testing of pharmaceuticals; scientific laboratory services; laboratory research and analysis in the fields of pharmaceuticals, chemicals, and personal-care products; product safety laboratory testing services in the fields of pharmaceuticals, chemicals, and personal-care products, namely, safety screening, determination and prediction of chemical toxicity, and risk assessment; Scientific research and design in the field of in-vitro products for scientific, laboratory, and medical research use; Scientific and technological services, namely, product design in the field of in vitro cell cultures for others; development of new products for others in the field of in vitro toxicology tools and biochemical toxicology solutions; | ACTIVE | — |
| 044 | Oncology testing services, namely, cancer screening services; Medical testing services relating to the diagnosis and treatment of disease and cancer; Providing medical testing services and information in the field of oncology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LifeNet Health
- Other trademarks owned by LifeNet Health
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LIFENET HEALTH GIVE HEALING EVERY ADVANTAGE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 11, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 7, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 26, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 26, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 30, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 30, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 30, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 30, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 30, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 26, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 26, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 31, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 2, 2023 | NWAP | NEW APPLICATION ENTERED | — |